Application en routine de la priorisation de l'analyse pharmaceutique vers les prescriptions à haut risque iatrogène

This study confirms the results reported by Leroy et al. In the current context, where time for pharmaceutical analysis is increasingly limited, this selective approach enables activity to be focused on potentially high-risk prescriptions.